559276 Sigma-AldrichRyanodine, High Purity - CAS 15662-33-6 - Calbiochem
Ryanodine, High Purity - CAS 15662-33-6, is a naturally occurring alkaloid that blocks the release of Ca2+ from the sarcoplasmic reticulum (IC50 = 10 nM for skeletal muscle).
More>> Ryanodine, High Purity - CAS 15662-33-6, is a naturally occurring alkaloid that blocks the release of Ca2+ from the sarcoplasmic reticulum (IC50 = 10 nM for skeletal muscle). Less<<Empfohlene Produkte
Übersicht
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 15662-33-6 | C₂₅H₃₅NO₉ |
Preis & Verfügbarkeit
| Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
|---|---|---|---|---|---|---|
| 559276-500UG |
|
Kst.-Ampulle | 500 μg |
|
— |
| Product Information | |
|---|---|
| CAS number | 15662-33-6 |
| ATP Competitive | N |
| Form | White solid |
| Hill Formula | C₂₅H₃₅NO₉ |
| Chemical formula | C₂₅H₃₅NO₉ |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | Ryanodine, High Purity - CAS 15662-33-6, is a naturally occurring alkaloid that blocks the release of Ca2+ from the sarcoplasmic reticulum (IC50 = 10 nM for skeletal muscle). |
| Biological Information | |
|---|---|
| Primary Target | Ca2+ transport and action in muscle |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | VM4025000 |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Bestellnummer | GTIN |
| 559276-500UG | 04055977192353 |
Documentation
Ryanodine, High Purity - CAS 15662-33-6 - Calbiochem SDB
| Titel |
|---|
Ryanodine, High Purity - CAS 15662-33-6 - Calbiochem Analysenzertifikate
| Titel | Chargennummer |
|---|---|
| 559276 |
Literatur
| Übersicht |
|---|
| Sorrentino, V., and Volpe, P. 1993. Trends Pharmacol. Sci. 14, 98. Sabbadini, R., et al. 1992. J. Biol. Chem. 267, 15475. Feher, J.J., and Lipford, G.B. 1985. Biochim. Biophys. Acta 813, 77. Marban, E., and Wier, W.G. 1985. Circ. Res. 56, 133. Sukto, J.L., et al. 1985. Fed. Proc. 44, 2984. |



